Skip to main content
Etropal AD logo

Etropal AD — Investor Relations & Filings

Listed
Ticker · ETR ISIN · BG1100001038 LEI · 747800F04CMOK74FIJ68 BSOBGN Manufacturing
Open in API
Filings indexed 92 across all filing types
Latest filing 2026-06-03 Annual Report
Country BG Bulgaria
Listing BSOBGN ETR · 2 venues

About Etropal AD

https://www.etropal.eu/

Etropal AD is a manufacturer of disposable medical devices, primarily focused on providing life-sustaining care for patients with end-stage renal disease. The company's core activities include the research, development, and production of a comprehensive range of hemodialysis consumables, such as capillary dialyzers. In addition to its focus on dialysis solutions, the company is also active in the field of orthopedics and traumatology. This secondary business line involves the manufacturing of endoprostheses, implants, specialized bioceramic materials, and surgical instruments. With over thirty years of experience, Etropal AD offers a broad spectrum of products that meet high standards of safety and quality.

Recent filings

Filing Released Lang Actions
691736-2_Konsol. 2026 po MSS _ETROPAL_Q1.pdf
Annual Report Classification · 88% confidence The document is a full set of consolidated financial statements (income statement, balance sheet, cash flow, statement of changes in equity) for the year ended 31 March 2026, including comparative figures for the prior year, preparer and board approval dates. It clearly contains substantive financial data for a full fiscal year rather than just an announcement or an interim/quarterly update. Therefore, this aligns with the definition of an Annual Report (10-K). Q1 2026
2026-06-03 Bulgarian
691737-3_KFO_2026_ETROPAL__belejki Consol Q1.pdf
Interim / Quarterly Report Classification · 94% confidence The document contains detailed explanatory notes (“Пояснителни бележки”) to a consolidated financial statement for the quarter ended 31 March 2026. It includes actual financial data, accounting policies, consolidation principles, and estimates—typical content of an interim/quarterly report under IFRS. Therefore it should be classified as an Interim / Quarterly Report rather than a simple publication announcement or another filing type. Q1 2026
2026-06-03 Bulgarian
691742-Management report Q1_2026cons.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed “Междинен консолидиран доклад” covering the company’s consolidated financial results for the first quarter of 2026, including actual financial data, charts, balance sheet and income statement figures, and risk factor disclosures. This aligns with the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-06-03 Bulgarian
691741-Etropal_Q1_2026_Additional_information.pdf
Interim / Quarterly Report Classification · 85% confidence The document is titled “Допълнителна информация към междинен финансов отчет за дейността на „Етропал“ АД към 31.03.2026 г.” (Additional information to the interim financial report as at 31 March 2026) and provides the required disclosures under Bulgarian regulation (accounting policy changes, shareholdings, related‐party transactions, litigation, etc.) for a quarter‐end reporting period. It is not announcing a report publication nor is it a mere certification or proxy statement. It forms part of the interim (quarterly) financial reporting package, containing substantive financial disclosures. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-06-03 Bulgarian
691738-годишни и шестмесечни справки на консолидирана основа.xlsx
Financial Supplement Data Classification · 100% confidence
2026-06-03 Norwegian Nynorsk
691744-Etropal_Q1_2026_Prilojenie_4.pdf
Regulatory Filings Classification · 82% confidence The document is a mandatory regulatory disclosure under Bulgarian Ordinance No. 2, listing items such as changes in control, insolvency proceedings, significant deals, auditor changes, legal proceedings, and other material events during the reporting period. It does not contain actual financial statements or detailed report content, nor does it announce the release of a full report; instead it is a compliance disclosure under continuous disclosure rules. This fits the “Regulatory Filings” category (RNS) as a general compliance/regulatory announcement.
2026-06-03 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.